問題疫苗

Beijing battles public anger over latest vaccine scandal

Beijing is seeking to quell public anger over the revelation that a pharmaceutical company distributed hundreds of thousands of faulty vaccines, sparking a nationwide outcry following a series of similar food and drug safety scandals. 

Regulators said that Changchun Changsheng Biotech had forged data during the production of some 110,000 rabies vaccines and disclosed that the same company had also sold more than 250,000 “substandard” diphtheria, tetanus and pertussis (DTP) vaccines to medical centres last year.

 Changsheng is China’s largest listed vaccine producer by revenue, with 110m doses of different vaccines sold domestically since 2012. 

您已閱讀17%(650字),剩餘83%(3106字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×